Crispr Therapeutics Stays Costly With Slower Casgevy Monetization And Patent Battle
Andy CRSP's Gene Modifying Expertise Has Lastly Been Accepted CRSP's Gene Modifying Expertise CRSP CRISPR Therapeutics AG (NASDAQ:CRSP) is a ...
Tuesday, April 15, 2025
Tag: CRISPR
Impact Of Gene Therapies And Casgevy On Crispr AG And The Industry (CRSP)
Bill Oxford CASGEVY approval CASGEVY is a groundbreaking gene therapy, owned by CRISPR Therapeutics AG (CRSP) and Vertex (VRTX) specifically ...
Another CRISPR approval not likely ‘any time soon’ – report (NASDAQ:CRSP)
Bill Oxford/iStock via Getty Images Following the recent FDA green light for the gene therapy Casgevy, "it is unlikely" that ...
Lilly, Scribe team up for neuro diseases CRISPR therapies
rommma Scribe Therapeutics is collaborating with Eli Lilly's unit (NYSE:LLY) Prevail Therapeutics and granted rights to its CRISPR X-Editing (XE) ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.